PDB-code
Browse kinase entries (page 174 of 282)
First 170 171 172 PreviousLast178 177 176 Next| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File |
|---|---|---|---|---|---|---|---|---|---|---|
 | MAP4K4 (HGK) | STE20 | STE | 4zp5 | B | - | Human | Show |  | |
| MAP4K4 (HGK) | STE20 | STE | 5di1 | A | 4-{6-amino-5-[4-(methylsulfonyl)phenyl]pyridin-3-yl}phenol | Human | Show | | |
| MAP4K4 (HGK) | STE20 | STE | 5di1 | B | - | Human | Show | | |
| MAP4K4 (HGK) | STE20 | STE | 5j95 | A | 1-{4-[6-amino-5-(4-chlorophenyl)pyridin-3-yl]phenyl}cyclopentane-1-carboxylic acid | Human | Show | | |
| MAP4K4 (HGK) | STE20 | STE | 5j95 | B | - | Human | Show | | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | A | A | (5s,7s)-n~3~-methyl-10-[3-methyl-3-(5-methyl-1,3-oxazol-2-yl)but-1-yn-1-yl]-6,7-dihydro-5h-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide | Human | Show | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | A | B | (5s,7s)-n~3~-methyl-10-[3-methyl-3-(5-methyl-1,3-oxazol-2-yl)but-1-yn-1-yl]-6,7-dihydro-5h-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide | Human | Show | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | B | A | - | Human | Show | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | B | B | - | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 1pme | A | 4-[5-(4-fluoro-phenyl)-2-(4-methanesulfinyl-phenyl)-3h-imidazol-4-yl]-pyridine | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 1tvo | A | 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1h-pyrazolo[3,4-c]pyridazin-3-amine | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 1wzy | A | 1-allyl-5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1h-pyrazolo[3,4-c]pyridazin-3-amine | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 2ojg | A | n,n-dimethyl-4-(4-phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 2oji | A | n-benzyl-4-[4-(3-chlorophenyl)-1h-pyrazol-3-yl]-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 2ojj | A | (s)-n-(1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl)-4-(4-(3-chlorophenyl)-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 2y9q | A | A | phosphoaminophosphonic acid-adenylate ester | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 2y9q | A | B | phosphoaminophosphonic acid-adenylate ester | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 2y9q | A | C | phosphoaminophosphonic acid-adenylate ester | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 3i5z | A | n-[(1s)-2-hydroxy-1-phenylethyl]-4-[5-methyl-2-(phenylamino)pyrimidin-4-yl]-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 3i60 | A | 4-{2-[(2-chlorophenyl)amino]-5-methylpyrimidin-4-yl}-n-[(1s)-2-hydroxy-1-phenylethyl]-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 3sa0 | A | A | norathyriol | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 3sa0 | A | B | norathyriol | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 3tei | A | phosphoaminophosphonic acid-adenylate ester | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 3w55 | A | (3s,5z,8s,9s,11e)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fmq | A | A | phosphoaminophosphonic acid-adenylate ester | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fmq | A | B | phosphoaminophosphonic acid-adenylate ester | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fux | A | trans-4-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)pyrimidin-2-yl]amino}cyclohexanol | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fuy | A | A | {4-[4-(3,5-dichlorophenyl)-1h-pyrazol-5-yl]-1h-pyrrol-2-yl}(morpholin-4-yl)methanone | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fuy | A | B | {4-[4-(3,5-dichlorophenyl)-1h-pyrazol-5-yl]-1h-pyrrol-2-yl}(morpholin-4-yl)methanone | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv0 | A | A | n-cyclohexyl-4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2-amine | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv0 | A | B | n-cyclohexyl-4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2-amine | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv1 | A | A | n-[(1s)-2-hydroxy-1-phenylethyl]-4-{4-[3-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl}-1h-pyrrole-2-carboxamide | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv1 | A | B | n-[(1s)-2-hydroxy-1-phenylethyl]-4-{4-[3-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl}-1h-pyrrole-2-carboxamide | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv2 | A | A | 4-[4-(3-chlorophenyl)-1h-pyrazol-5-yl]-n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-1h-pyrrole-2-carboxamide | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv2 | A | B | 4-[4-(3-chlorophenyl)-1h-pyrazol-5-yl]-n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-1h-pyrrole-2-carboxamide | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv3 | A | A | ethyl n-{2-chloro-4-[5-(5-{[(1s)-1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]carbamoyl}-1h-pyrrol-3-yl)-1h-pyrazol-4-yl]benzyl}glycinate | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv3 | A | B | ethyl n-{2-chloro-4-[5-(5-{[(1s)-1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]carbamoyl}-1h-pyrrol-3-yl)-1h-pyrazol-4-yl]benzyl}glycinate | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv4 | A | A | 9-(dimethylamino)-2-[(3-hydroxyphenyl)amino]-5,6-dihydrothieno[3,4-h]quinazoline-7-carbonitrile | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv4 | A | B | 9-(dimethylamino)-2-[(3-hydroxyphenyl)amino]-5,6-dihydrothieno[3,4-h]quinazoline-7-carbonitrile | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv5 | A | n-[(1s)-2-hydroxy-1-phenylethyl]-4-(5-methyl-2-phenylpyrimidin-4-yl)-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv6 | A | n-[(1s)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-(2-{[(2s)-1-hydroxybutan-2-yl]amino}-5-methylpyrimidin-4-yl)-1h-pyrrole-2-carboxamide | Human | Show | | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv7 | A | A | 4-(3-chlorophenyl)-5-{2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}-2-{[2-(piperidin-1-yl)ethyl]amino}thiophene-3-carbonitrile | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv7 | A | B | 4-(3-chlorophenyl)-5-{2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}-2-{[2-(piperidin-1-yl)ethyl]amino}thiophene-3-carbonitrile | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv8 | A | A | 6-({4-[(3-cyclopropyl-1h-pyrazol-5-yl)amino]-5-(phenylamino)pyrimidin-2-yl}amino)-1,2-dihydro-3h-indazol-3-one | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv8 | A | B | 6-({4-[(3-cyclopropyl-1h-pyrazol-5-yl)amino]-5-(phenylamino)pyrimidin-2-yl}amino)-1,2-dihydro-3h-indazol-3-one | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv9 | A | A | 3-[4-(2,3-difluorophenyl)-1,2-oxazol-5-yl]-5-(pyridin-4-yl)-1h-pyrrolo[2,3-b]pyridine | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv9 | A | B | 3-[4-(2,3-difluorophenyl)-1,2-oxazol-5-yl]-5-(pyridin-4-yl)-1h-pyrrolo[2,3-b]pyridine | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4g6n | A | A | 3-(4-chlorophenyl)-4,5,6,7-tetrahydro-1h-indazole | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4g6n | A | B | 3-(4-chlorophenyl)-4,5,6,7-tetrahydro-1h-indazole | Human | Show | |
| MAPK1 (Erk2) | MAPK | CMGC | 4g6o | A | 4-{4-[4-(aminomethyl)-3-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl}-n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-1h-pyrrole-2-carboxamide | Human | Show | |
